Very interestingly, the tumor number from anti-CD25 treated Tipe2-/- mice was significantly lower compared with anti-CD25 treated Tipe2+/+ controls (Fig. 6B), especially tumors with size more than 2 mm (Fig. 6C, left panel). The gene discussed is TIPE2; the disease is neoplasm.